Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Individualization of Bladder Cancer Therapy: the Role of Microbiome in BCG Responsiveness Prediction

NCT05204199 is registered in ClinicalTrials.gov with Cédric Poyet as lead sponsor.

NCT NCT05204199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05204199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Individualization of Bladder Cancer Therapy: the Role of Microbiome in BCG Responsiveness Prediction
Lead sponsor
Cédric Poyet
Phase
Observational
Overall status
Unknown status
Start date
February 22, 2022
Completion date
October 20, 2025
Enrollment
120 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, microbiome